P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT)
Askeland, F. B., Rasmussen, A.‐M., Lysen, A., Haukås, E., Eilertsen, A., Moksnes, M., Tsykunova, G., Vik, A., Eiken, B. D., Sørbø, J. H., Rolke, J., Sand, K. O., Hallstensen, R. F., Myrseth, L., Slørdahl, T. S., Schjesvold, F.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
Berentsen, Sigbjørn, Tjønnfjord, Geir E., Brudevold, Robert, Gjertsen, Bjørn T., Langholm, Ruth, Løkkevik, Erik, Sørbø, Jon Hjalmar, Ulvestad, Elling
Published in British journal of haematology (01.10.2001)
Published in British journal of haematology (01.10.2001)
Get full text
Journal Article
Primary chronic cold agglutinin disease: a population based clinical study of 86 patients
Berentsen, S, Ulvestad, E, Langholm, R, Beiske, K, Hjorth-Hansen, H, Ghanima, W, Sorbo, JH, Tjonnfjord, GE
Published in Haematologica (Roma) (01.04.2006)
Get full text
Published in Haematologica (Roma) (01.04.2006)
Journal Article